Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Pathologic Complete Response × nimotuzumab × Head & Neck × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Nasopharyngeal Carcinoma 18 Squamous Cell Carcinoma of Head and Neck 10 Head and Neck Neoplasms 8 Recurrence 2 Nasopharyngeal Neoplasms 2 Pathologic Complete Response 1 Oropharyngeal Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Diseases 1 Hypopharyngeal Neoplasms 1 Carcinoma 1

Interventions

toripalimab 1 nimotuzumab 1 Radiotherapy 1 Neoadjuvant Therapy 1 Immunotherapy 1 Carboplatin 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07353723 2026-01-20

Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar Cancer

Tang-Du Hospital

Phase 2 Recruiting

Pathologic Complete Response, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡